Cross-match testing
Showing 1 - 25 of >10,000
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Capivasertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Trametinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Trametinib Dimethyl Sulfoxide
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Aug 13, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Defactinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Defactinib Hydrochloride
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Adavosertib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Afatinib
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Afatinib Dimaleate
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 28, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Crizotinib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Feb 4, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Taselisib)
Active, not recruiting
- Advanced Lymphoma
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Feb 4, 2022
Urine-based Molecular Testing vs Cystoscopy for Surveillance of
Not yet recruiting
- Non-muscle Invasive Bladder Cancer
- +2 more
- CxBladder Monitor
- Cystoscopy
-
Scottsdale, Arizona
- +2 more
Nov 14, 2023
Using Exercise-testing to Explore Patient Differences in Severe
Not yet recruiting
- Asthma
- cardiopulmonary exercise stress test (CPEST)
-
Belfast, Northern Ireland, United KingdomQueen's University Belfast
Feb 16, 2023
FGFR Testing by Either ctDNA Blood Testing or Standard Tumor
Recruiting
- Metastatic Bladder Cancer
- Metastatic Urothelial Carcinoma
- FGFR Testing
-
Calgary, Alberta, Canada
- +6 more
Nov 8, 2023
Health-promoting Lifestyle in a Genetic Counseling Clinic
Completed
- Breast Cancer
- Genetic Testing
- genetic testing
-
Shanghai, ChinaFudan University Shanghai Cancer Center
Sep 14, 2022
Physical Capacity Among Patients Treated With Periacetabular
Completed
- Hip Dysplasia
- +2 more
- Testing of physical capacity
-
Copenhagen, Hvidovre, DenmarkDepartment of Orthopedic Surgery, Copenhagen University Hospital
Nov 8, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor Trial in Philadelphia (Biopsy,
Active, not recruiting
- Advanced Lymphoma
- +5 more
- Biopsy
- +3 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Aug 5, 2022
Rate of Torque Development in Adolescents With Osgood-Schlatter
Recruiting
- Osgood-Schlatter Disease
- Rate of torque development testing of knee flexors and knee extensors using a fixated handheld dynamometer (MicroFet 2, Hoggan, Scientific L.L.C., Salt Lake City, USA), sampling rate of 100hz)
-
Hvidovre, DenmarkHvidovre Hospital
Mar 15, 2023
OGTT in Post-pancreatitis Diabetes Mellitus for Diagnosis and
Recruiting
- Chronic Pancreatitis
- +3 more
- blood test
- Continuous Glucose Monitor
-
Shanghai, Shanghai, ChinaDepartment of Gastroenterology, Changhai Hospital
Aug 11, 2023
Psychometric Testing of Norwegian Foot Functional Index Revised,
Completed
- Foot Diseases
- Plantar Fascitis
-
Oslo, NorwayOslo University Hospital, Department of Physical Medicine and Re
Apr 19, 2022
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (FGFR Inhibitor
Completed
- Advanced Lymphoma
- +5 more
- FGFR Inhibitor AZD4547
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Jun 8, 2021
Malignant Solid Tumor Trial in Philadelphia (Biopsy, Biospecimen Collection, Echocardiography)
Active, not recruiting
- Malignant Solid Neoplasm
- Biopsy
- +5 more
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Nov 15, 2023
"Functional Overlay" in Patients With Movement Disorders
Recruiting
- Conversion Disorder
- +3 more
- Neurological examination
- +4 more
-
Graz, Styria, AustriaMedical University of graz
Jul 5, 2023
Pulmonary Disease Among Systemic Lupus Erythematosus
Enrolling by invitation
- Lupus Erythematosus, Systemic
- Pulmonary Disease
- Multidisciplinary discussion
-
Odense, Region Southern Denmark, DenmarkOdense University Hospital
Oct 11, 2023
Advanced Lymphoma, Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid Cell Tumor Trial in Philadelphia (Nivolumab)
Completed
- Advanced Lymphoma
- +5 more
- Nivolumab
-
Philadelphia, PennsylvaniaECOG-ACRIN Cancer Research Group
Mar 15, 2021
Parkinson Disease, Orthostatic Hypotension Trial in Salt Lake City (Autonomic testing on and off levodopa)
Recruiting
- Parkinson Disease
- Orthostatic Hypotension
- Autonomic testing on and off levodopa
-
Salt Lake City, UtahUniversity of Utah
Aug 1, 2022
Shoulder Range of Motion and Isometric Strength Before and
Recruiting
- Athletes
-
Rawalpindi, Federal, PakistanMaham Nasir
Oct 4, 2023
Aphasia Trial (Speeded anomia therapy)
Not yet recruiting
- Aphasia
- Speeded anomia therapy
- (no location specified)
Aug 20, 2022
3D Echocardiography and Cardiopulmonary Exercise Testing in
Recruiting
- Single-ventricle
- Congenital Heart Disease
-
Montpellier, FranceUh Montpellier
Nov 1, 2021